Can Creatine Monohydrate Support Energy Levels and Brain Fog in Long COVID and ME/CFS?

To understand how creatine monohydrate works, we must first look at how the human body generates and utilizes energy at the most fundamental cellular level. The primary energy currency of all living cells is a molecule called adenosine triphosphate (ATP). ATP is essentially a microscopic rechargeable battery that powers everything from the contraction of your heart muscle to the firing of neurons in your brain. When a cell needs to perform work, it breaks one of the phosphate bonds in the ATP molecule, releasing a burst of energy and converting the molecule into adenosine diphosphate (ADP). For cellular functions to continue uninterrupted, this ADP must be rapidly converted back into ATP.

This is where the phosphocreatine (PCr) system comes into play. Creatine is a naturally occurring nitrogenous organic acid that is synthesized in the liver, kidneys, and pancreas from three amino acids: arginine, glycine, and methionine. Once synthesized or ingested through diet and supplementation, creatine is transported through the bloodstream and taken up by tissues with high and fluctuating energy demands, primarily skeletal muscle and the brain. Inside these cells, approximately two-thirds of the creatine is phosphorylated to become phosphocreatine. This phosphocreatine pool acts as a rapid, localized energy reserve—a biological buffer that stands ready to instantly recharge ATP when cellular demand spikes.

Unlike other energy-producing pathways in the body, such as glycolysis (the breakdown of glucose) or oxidative phosphorylation (the oxygen-dependent process in the mitochondria), the phosphocreatine system does not require oxygen and does not produce acidic byproducts like lactate. It is the fastest energy delivery system in the human body. By maintaining a robust intracellular pool of phosphocreatine, cells can sustain high-intensity work and maintain metabolic homeostasis even when other energy systems are slow to respond or temporarily impaired by illness.

The magic of the phosphocreatine system is governed by a highly specialized enzyme known as creatine kinase (CK). During periods of high metabolic demand—whether you are standing up, trying to recall a specific word, or walking up a flight of stairs—creatine kinase catalyzes a reversible biochemical reaction. It rapidly strips the phosphate group from phosphocreatine and donates it to the depleted ADP molecule, instantly regenerating a fresh molecule of ATP. This reaction occurs in a fraction of a second, ensuring that the cellular machinery does not stall due to an energy deficit.

Furthermore, the creatine kinase system acts as a spatial energy shuttle within the cell. Mitochondria, often referred to as the powerhouses of the cell, generate ATP deep within their inner membranes. However, this ATP must be transported to the specific sites within the cell where work is actually being done, such as the myofibrils in muscle cells or the ion pumps in neuronal synapses. The "creatine phosphate shuttle" facilitates this transport. ATP generated in the mitochondria transfers its phosphate to creatine, creating phosphocreatine, which then rapidly diffuses across the cell to the sites of energy consumption. Once there, creatine kinase reverses the reaction, delivering the ATP exactly where it is needed.

In healthy individuals, this elegant system operates seamlessly, matching energy supply with energy demand. However, when the body is subjected to severe metabolic stress, chronic inflammation, or post-viral dysfunction, the intracellular pools of creatine and phosphocreatine can become severely depleted. When the buffer runs dry, the cell is forced to rely on slower, less efficient energy pathways, leading to rapid fatigue, cellular distress, and the accumulation of metabolic waste products.

While creatine is most famous for its concentration in skeletal muscle, its role in the central nervous system is equally profound. The human brain is an incredibly energy-hungry organ. Despite accounting for only about 2% of total body mass, the brain consumes a staggering 20% of the body's resting energy. Neurons require a constant, massive supply of ATP to maintain electrical ion gradients, synthesize and release neurotransmitters, and support the synaptic plasticity required for learning and memory.

Recent neuroimaging research highlights that higher rates of brain energy generation—specifically catalyzed by the creatine kinase reaction—are positively correlated with stronger "functional connectivity." This refers to the synchronization of distant brain regions required to execute complex cognitive tasks, maintain focus, and process information quickly. The brain actually has its own localized system for synthesizing creatine, underscoring just how critical this molecule is for neurological survival.

However, the brain's high energy demand makes it uniquely vulnerable to bioenergetic crises. When the brain's phosphocreatine buffer is compromised by hypoxia, sleep deprivation, or neuroinflammation, the resulting energy deficit manifests clinically as cognitive impairment, delayed processing speed, and severe mental fatigue—a constellation of symptoms frequently described by patients as "brain fog." Supporting the brain's bioenergetic capacity through targeted supplementation has therefore become a major focus of modern neurological research.

To understand why creatine monohydrate is so relevant to conditions like Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), we must examine how these illnesses disrupt cellular energy production. Emerging research suggests that severe viral infections, such as SARS-CoV-2, can trigger long-lasting mitochondrial dysfunction. Mitochondria are responsible for the vast majority of cellular ATP production through a process called oxidative phosphorylation. In many post-viral patients, this process becomes severely impaired, leading to a chronic, systemic energy deficit.

Studies investigating the skeletal muscle of Long COVID patients have revealed consistent intrinsic abnormalities. Researchers have observed impairments in mitochondrial respiration, specifically complex I dysfunction within the electron transport chain. Additionally, there is evidence of endothelial pathology, including capillary basal lamina thickening and the presence of microclots, which restrict the delivery of oxygen and vital nutrients to the tissues. Without adequate oxygen, the mitochondria cannot produce ATP efficiently, forcing the cells to rely on less efficient, oxygen-independent pathways.

This metabolic shift leads to a greater reliance on glycolysis, which produces energy quickly but yields far less ATP per molecule of glucose and results in the rapid accumulation of lactate and other acidic byproducts. This shift toward glycolytic metabolism explains the reduced aerobic capacity and early lactate accumulation frequently observed during cardiopulmonary exercise testing in patients with ME/CFS and Long COVID. The cells are essentially starving for energy while simultaneously drowning in metabolic waste.

The clinical manifestation of this profound cellular energy crisis is post-exertional malaise (PEM), a hallmark symptom of both ME/CFS and Long COVID. PEM is characterized by a disproportionate and debilitating exacerbation of symptoms following even minor physical, cognitive, or emotional exertion. For a healthy person, a short walk or a focused conversation might slightly deplete cellular energy stores, which are quickly replenished. For someone with a compromised bioenergetic system, that same exertion can completely drain the cellular battery, triggering a systemic crash.

This reality is often described using the "Energy Envelope" theory. Patients have a strictly limited daily allowance of energy. If they push beyond this envelope, they do not just experience normal tiredness; their cells enter a state of metabolic distress. Research indicates that prolonged exposure to the sera of ME/CFS and Long COVID patients induces significant contractile dysfunction in skeletal muscle tissues, leading to disturbances in calcium homeostasis and mitochondrial fragmentation. The mitochondria physically alter their shape into a toroidal (donut-like) conformation, signaling a progression from compensatory adaptation to structural and metabolic collapse.

During a PEM crash, the intracellular pools of ATP and phosphocreatine are severely depleted, and the damaged mitochondria are unable to resynthesize them quickly enough. This local tissue hypoxia and energy failure drive intense muscle pain, profound weakness, and a systemic inflammatory response. Understanding this mechanism is crucial because it validates that PEM is not a psychological phenomenon or simple "deconditioning"—it is a measurable, physiological failure of cellular bioenergetics.

The bioenergetic crisis of chronic illness is not limited to the skeletal muscles; it heavily impacts the central nervous system. The cognitive impairment commonly referred to as "brain fog" is a direct result of neuroinflammation and brain energy depletion. When the brain's mitochondria are dysfunctional, or when cerebral blood flow is reduced (as often seen in dysautonomia and postural orthostatic tachycardia syndrome, or POTS), neurons struggle to generate the ATP required to maintain normal synaptic activity.

This energy deficit specifically impacts areas of the brain responsible for executive function, working memory, and information processing speed. Patients frequently report struggling to find the right words, losing their train of thought, or feeling completely overwhelmed by sensory input. The brain is essentially operating in a low-power mode, prioritizing basic survival functions over complex cognitive tasks.

Furthermore, chronic immune activation and mast cell activation syndrome (MCAS), which frequently co-occur with Long COVID and ME/CFS, release inflammatory cytokines that can cross the blood-brain barrier. This neuroinflammation further disrupts the creatine kinase system in the brain, reducing the availability of phosphocreatine. Restoring this critical energy buffer is essential for alleviating the neurological burden of these complex chronic conditions.

Supplementing with creatine monohydrate offers a direct, mechanistic intervention to support cells struggling with mitochondrial dysfunction. By providing the body with an exogenous source of creatine, supplementation significantly increases the total intracellular pools of both free creatine and phosphocreatine. This effectively expands the cellular energy buffer, giving the cells a larger reservoir of rapid-access energy to draw upon during times of metabolic stress.

For patients with Long COVID or ME/CFS, a larger phosphocreatine pool means that the cells are less reliant on the impaired mitochondrial oxidative phosphorylation pathways for immediate energy needs. When a patient engages in an activity that demands energy, the enhanced phosphocreatine buffer can rapidly regenerate ATP via the creatine kinase reaction, delaying the onset of cellular energy depletion. This can help stabilize the metabolic environment within the cell and reduce the premature shift toward lactate-producing glycolysis.

Additionally, by maintaining stable ATP levels, creatine helps prevent the cascade of intracellular events that lead to oxidative stress, reduced cellular pH (acidosis), and programmed cell death (apoptosis). It acts as a metabolic shield, protecting the delicate cellular machinery from the damaging effects of energy failure. This stabilization of cellular bioenergetics is a foundational step in supporting overall physical and cognitive endurance.

One of the most exciting areas of recent medical research is the ability of supplemental creatine to cross the blood-brain barrier and support neurological function. Unlike muscle cells, which rapidly absorb circulating creatine from the bloodstream, the brain has a highly restrictive barrier and relies on a specific sodium-dependent transporter (known as SLC6A8 or CrT1) to import creatine. While the brain synthesizes some of its own creatine, clinical studies have proven that oral supplementation can significantly increase total brain creatine and phosphocreatine content by 3% to 10%, and up to 15% in some cases.

This elevated energetic ceiling in the brain results in measurable cognitive and neuroprotective benefits. By increasing the phosphocreatine-to-ATP ratio in specific brain regions, creatine supplementation provides neurons with the energy required to maintain functional connectivity and process information efficiently. This is particularly crucial when the brain's baseline energy generation is compromised by post-viral neuroinflammation or the chronic stress of living with a debilitating illness.

Beyond raw cognitive performance, the creatine-phosphocreatine system provides long-term neuroprotection. It helps reverse mitochondrial dysfunction in neurons, stabilizes cellular membranes, and maintains energy homeostasis even when cells are subjected to neurotoxic stress. By acting as a neuroprotective buffer, creatine may help mitigate the long-term neurological impacts of post-viral syndromes and support the gradual recovery of cognitive clarity.

In addition to its bioenergetic and neurological benefits, creatine monohydrate plays a vital role in maintaining skeletal muscle health. Patients with severe ME/CFS, Long COVID, or dysautonomia often experience prolonged periods of bedbound or housebound status due to debilitating fatigue and orthostatic intolerance. This forced inactivity inevitably leads to muscle atrophy and a loss of physical strength, which further compounds the difficulty of performing daily activities.

Creatine supplementation is a well-established intervention for promoting skeletal muscle maintenance and hypertrophy. It works through several mechanisms: it increases intracellular water retention, which acts as an anabolic signal for muscle protein synthesis; it reduces the breakdown of muscle proteins; and it enhances the function of satellite cells, which are crucial for muscle repair and regeneration. By preserving muscle mass, creatine helps maintain a baseline level of physical strength and functional independence.

Furthermore, by improving the efficiency of the "creatine phosphate shuttle" between the mitochondria and the myofibrils, creatine ensures that the muscle fibers have the ATP required to contract forcefully and efficiently. This can translate to tangible improvements in physical function, such as increased handgrip strength and a greater ability to tolerate the physical demands of daily life without immediately triggering severe post-exertional malaise.

While creatine monohydrate is not a cure for complex chronic illnesses, its ability to restore cellular energy buffers makes it a powerful tool for managing specific, debilitating symptoms. By acting at the molecular level to regenerate ATP, creatine targets the downstream effects of mitochondrial dysfunction and post-viral metabolic stress. Here are the primary symptoms that creatine supplementation may help manage:

When selecting a creatine supplement, the specific form and physical properties of the powder matter significantly, especially for patients with sensitive digestive systems. Micronized creatine monohydrate is a specialized form of standard creatine that has been mechanically processed to reduce its particle size—typically making the particles up to 20 times smaller. It is important to note that the active chemical compound remains identical, and the overall systemic bioavailability of both forms is exceptionally high (roughly 95%).

The true advantage of micronized creatine lies in its water solubility and gastrointestinal tolerability. Standard creatine monohydrate has larger particles that often resist dissolving, leaving a gritty residue at the bottom of the glass. If consumed, this undissolved powder can pull excess water into the intestines through osmosis, leading to gastrointestinal distress, bloating, and cramping. Micronized creatine's vastly increased surface area allows it to dissolve almost completely in liquid.

Because it dissolves fully, micronized creatine is absorbed into the bloodstream smoothly and efficiently, preventing the pooling of undissolved powder in the gut. For patients with complex chronic conditions who may already be dealing with irritable bowel syndrome (IBS), mast cell activation syndrome (MCAS), or general gastrointestinal sensitivity, choosing a micronized, unflavored, and unsweetened powder is a crucial step in ensuring the supplement is well-tolerated.

Clinical studies outline two primary methods for initiating creatine supplementation: the "Loading" approach and the "Gradual" maintenance approach. The loading phase is designed to rapidly saturate muscle and brain phosphocreatine stores. This typically involves taking 20 to 25 grams per day (or 0.3 grams per kilogram of body weight) for 5 to 7 days. To prevent stomach discomfort, this high dose must be divided into four or five smaller servings (e.g., 5 grams each) spread evenly throughout the day.

Alternatively, the gradual approach involves taking a standard maintenance dose of 3 to 5 grams per day (or 0.03 to 0.05 grams per kilogram of body weight) from the very beginning. While this method takes longer to achieve peak cellular saturation—typically 3 to 4 weeks—it achieves the exact same long-term bioenergetic benefits. For patients with chronic illness, the gradual approach is often highly recommended, as it minimizes the risk of temporary water retention and allows the body to adapt slowly to the new metabolic support.

It is also important to consider the unique kinetics of the blood-brain barrier. Because the brain is highly resistant to taking up creatine compared to skeletal muscle, some clinical trials targeting severe cognitive impairment utilize higher sustained doses (e.g., 8 to 10 grams per day) to ensure adequate central nervous system saturation. Patients should work closely with their healthcare provider to determine the optimal dosing strategy for their specific neurological and physical symptoms.

Creatine does not have an acute stimulant effect, meaning the exact timing of the dose matters less than consistent, daily intake. However, the physiological environment in which you take creatine can influence how efficiently it is transported into the cells. Clinical research indicates that taking creatine alongside a source of carbohydrates or protein can significantly enhance its cellular uptake.

This enhanced absorption is driven by insulin. When you consume carbohydrates, your body releases insulin, which acts as a key to unlock cellular receptors, allowing glucose and nutrients—including creatine—to enter the muscle and brain cells more rapidly. A recent trial involving Long COVID patients demonstrated that co-administering creatine with a small amount of glucose successfully elevated brain creatine across more regions than creatine alone.

For practical daily use, mixing an unflavored micronized creatine powder into a smoothie, a glass of juice, or taking it alongside a balanced meal can help optimize its delivery to the tissues that need it most. Consistency is paramount; creatine should be taken daily, even on days when you are resting or pacing aggressively, to maintain saturated intracellular stores.

Creatine monohydrate is one of the most rigorously tested nutritional supplements in the world, backed by decades of peer-reviewed safety data. However, a persistent myth remains that creatine supplementation damages the kidneys. A comprehensive 2025 systematic review of kidney function definitively refutes this in healthy individuals. While creatine supplementation causes a modest, transient increase in serum creatinine (a normal metabolic byproduct of creatine breakdown), it does not cause any significant changes in Glomerular Filtration Rate (GFR), which is the true measure of kidney health.

The rise in serum creatinine simply reflects the increased metabolic turnover of a larger phosphocreatine pool, not renal impairment. Large-scale safety analyses monitoring continuous creatine use for up to 14 years have observed no detrimental effects on kidney or liver function. However, individuals with pre-existing kidney disease or those taking nephrotoxic medications should consult their physician before starting creatine, as their compromised kidneys may struggle to filter the excess creatinine.

Finally, because creatine is an osmolytic compound—meaning it draws water into the intracellular space—proper hydration is essential. Patients may notice a slight increase in body weight (typically 1 to 3 pounds) during the initial weeks of supplementation due to this beneficial intracellular hydration. Ensuring adequate daily water and electrolyte intake will help support this cellular volumization and prevent any feelings of systemic dehydration.

The application of creatine monohydrate for post-viral syndromes is rapidly expanding, with several recent clinical trials demonstrating highly promising results. A landmark randomized, double-blind trial by Ostojic et al. (2023) investigated the effects of 4 grams per day of creatine over six months in patients with post-COVID-19 fatigue syndrome. The researchers found that supplementation led to a significant increase in creatine levels in both leg muscles and across the brain. By the six-month mark, patients reported drastic, statistically significant improvements in general fatigue, breathing difficulties, body aches, and concentration issues compared to the placebo group.

Building on this, a 2024 double-blind trial by Slankamenac et al. tested an 8-gram daily dose of creatine, both alone and co-administered with glucose, in Long COVID patients over eight weeks. The group receiving the creatine-glucose combination exhibited the most substantial improvements in physical endurance on a treadmill, alongside marked decreases in both mental and physical fatigue. This study highlighted the synergistic effect of insulin-mediated cellular uptake in overcoming post-viral bioenergetic resistance.

Most recently, a 2025 randomized controlled trial by Santos et al. compared different dosages in 67 Long COVID patients. They found that a moderate dose of 6 grams per day resulted in a statistically significant reduction in Piper Fatigue Scale scores and a significant increase in handgrip strength (+3.33 kgf) after just four weeks. Interestingly, a higher dose of 18 grams per day did not yield significantly better results, suggesting that a moderate, consistent dose is an optimal therapeutic target for physical fatigue.

The bioenergetic parallels between Long COVID and ME/CFS have led researchers to investigate creatine's efficacy in chronic fatigue syndrome populations. A fascinating 2024 feasibility study conducted at Oxford University (Godlewska et al.) utilized advanced 3-Tesla brain Magnetic Resonance Spectroscopy (MRS) to physically measure brain chemistry in ME/CFS patients before and after a six-week intervention of 16 grams of creatine per day.

The MRS imaging proved definitively that creatine effectively crosses the blood-brain barrier in ME/CFS patients. The scans revealed an 8.3% increase of creatine in the pregenual anterior cingulate cortex (pgACC) and a 2.9% increase in the dorsolateral prefrontal cortex. Clinically, these biochemical changes translated to decreased overall fatigue, significantly faster reaction times on cognitive testing, and increased physical handgrip strength.

Crucially, the researchers noted that the degree of creatine increase in the brain directly correlated with the patients' improvements in reaction time. This provides compelling, objective evidence that the cognitive dysfunction ("brain fog") experienced in ME/CFS is directly tied to a reversible depletion of cerebral energy stores, and that targeted supplementation can help restore this vital metabolic balance.

Beyond specific post-viral syndromes, massive reviews of clinical data confirm creatine's profound impact on general brain health. A robust 2024 systematic review and meta-analysis published in Frontiers in Nutrition evaluated 16 randomized controlled trials involving nearly 500 adult participants. The aggregated data revealed that creatine supplementation had a statistically significant positive effect on short-term memory, information processing speed, and attention time.

Similarly, a 2023 meta-analysis in Nutrition Reviews focused specifically on memory performance across different age groups. The researchers found that while young, healthy individuals saw modest benefits, older adults and individuals with underlying health conditions or metabolic stress experienced highly significant improvements in memory recall and cognitive endurance. The effect sizes in these vulnerable populations were considered large by statistical standards.

These meta-analyses also highlighted that populations with naturally lower baseline tissue levels of creatine—such as vegans, vegetarians, and post-menopausal women—frequently demonstrate the most dramatic cognitive improvements following supplementation. For patients navigating the complex dietary restrictions often required by understanding mast cell activation syndrome or severe gastrointestinal issues, an unflavored creatine powder can serve as a vital tool for bridging these nutritional gaps and supporting neurological resilience.

Living with a complex chronic illness like Long COVID, ME/CFS, or dysautonomia often feels like a constant battle against an invisible, draining force. The profound fatigue, unpredictable crashes, and dense brain fog are not signs of weakness or deconditioning; they are the clinical manifestations of a cellular bioenergetic system in distress. Understanding the physiological reality of your symptoms is a crucial step toward finding effective, validating management strategies.

While the clinical data supporting creatine monohydrate is highly promising, it is important to remember that no single supplement is a cure for these complex conditions. Creatine is best utilized as one foundational pillar of a comprehensive management plan. It works synergistically with aggressive pacing strategies, heart rate monitoring, optimal hydration for managing dysautonomia, and targeted medical care. By expanding your cellular energy buffer, creatine may help provide the metabolic stability needed to engage more safely in daily activities and survive the holidays or busy seasons with a chronic illness.

As always, it is essential to consult with your healthcare provider before introducing any new supplement into your regimen, especially if you have pre-existing kidney concerns or are taking multiple medications. Together, you can determine the optimal dosing strategy and monitor your progress. By combining cutting-edge nutritional science with compassionate, individualized care, we can continue to build a path toward better energy, clearer thinking, and improved quality of life.